CRT 2025

Late-Breaking Clinical Trials Structural and LAA

SMART 2-Year Data Update

Speaker(s)

• 

  Howard C. Herrmann, MD, FACC, MSCAI

  John Bryfogle Professor of Cardiovascular Medicine, Emeritus
  Perelman School of Medicine at the University of Pennsylvania
  Philadelphia, Pennsylvania, United States

  Disclosure(s): Abbott: Grant/Research Support (Ongoing); Affluent Medical: Consultant (Ongoing); Caranx: Consultant (Ongoing); Edwards Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Massachusetts Medical Society: Editorial consultant (Ongoing); Medtronic: Consultant (Ongoing), Grant/Research Support (Ongoing); Microinterventional Devices: Consultant (Ongoing); Shockwave: Grant/Research Support (Ongoing); Wells Fargo: Consultant (Ongoing)